BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22088206)

  • 1. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
    Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
    Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
    Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia.
    Panidis D; Georgopoulos NA; Piouka A; Katsikis I; Saltamavros AD; Decavalas G; Diamanti-Kandarakis E
    Gynecol Endocrinol; 2011 Aug; 27(8):587-92. PubMed ID: 20836726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome.
    Crisosto N; Codner E; Maliqueo M; Echiburú B; Sánchez F; Cassorla F; Sir-Petermann T
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2739-43. PubMed ID: 17488788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and antimüllerian hormone in mothers with polycystic ovary syndrome and their newborns.
    Vanky E; Carlsen SM
    Fertil Steril; 2012 Feb; 97(2):509-15. PubMed ID: 22154766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.
    Loverro G; Lorusso F; De Pergola G; Nicolardi V; Mei L; Selvaggi L
    Gynecol Endocrinol; 2002 Jun; 16(3):217-24. PubMed ID: 12192894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
    Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
    J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
    Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
    Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome.
    Crisosto N; Ladrón de Guevara A; Echiburú B; Maliqueo M; Cavada G; Codner E; Paez F; Sir-Petermann T
    Fertil Steril; 2019 Feb; 111(2):381-388. PubMed ID: 30527840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive Ovarian Growth in a Woman With Severe Insulin-Resistant Polycystic Ovary Syndrome Receiving GnRH Analogue.
    Singh P; Agress A; Madrigal VK; Magyar C; Ostrzega N; Chazenbalk GD; Dumesic DA
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2796-2800. PubMed ID: 30759233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.
    Tomova A; Deepinder F; Robeva R; Kirilov G; Mechandjiev Z; Kumanov P
    Horm Metab Res; 2011 Sep; 43(10):723-7. PubMed ID: 21932178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Nafiye Y; Sevtap K; Muammer D; Emre O; Senol K; Leyla M
    Fertil Steril; 2010 Apr; 93(6):1864-9. PubMed ID: 19171332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
    Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
    Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of different hormone therapies on anti-müllerian hormone serum levels in anovulatory women of reproductive age.
    Fábregues F; Castelo-Branco C; Carmona F; Guimerá M; Casamitjana R; Balasch J
    Gynecol Endocrinol; 2011 Apr; 27(4):216-24. PubMed ID: 20500102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased anti-Müllerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome.
    Sir-Petermann T; Codner E; Maliqueo M; Echiburú B; Hitschfeld C; Crisosto N; Pérez-Bravo F; Recabarren SE; Cassorla F
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3105-9. PubMed ID: 16720659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.